The global preclinical imaging market is experiencing significant growth, propelled by increased R&D spending, adoption of ...

Researchers at Moffitt Cancer Center have developed a new tool to predict how cancer cells evolve. By focusing on chromosome ...

Cancer doesn’t evolve by pure chaos. Scientists have developed a powerful new method that reveals the hidden rules guiding how cancer cells gain and lose whole chromosomes—massive genetic shifts that ...

Traditional cell therapies rely on “clean targets” – antigens that are found on cancer cells but not on healthy cells. Where ...

Techne, bioMerieux, Roche, Lonza Group, Miltenyi Biotec India and More Cell and Gene Therapy Manufacturing QC Market Cell and ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including ...

For decades, scientists have known that bacteria can exchange genetic material, in a process called horizontal gene transfer. This allows bacteria to rapidly evolve new traits, such as antibiotic ...

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma. A next-generation "armored" CAR T cell therapy ...

A groundbreaking phase 2 trial explores a novel, chemotherapy-free immunotherapy for relapsed indolent B-cell lymphomas, aiming to enhance patient outcomes.

Single-cell technologies uncover how leukemia cells evolve, resist therapy, and survive through cell-to-cell communication.